Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Safety and Immunogenicity of 20-valent Pneumococcal Conjugate Vaccine According to Number and Timing of Primary Series Doses.
Journal: The Pediatric infectious disease journal
Published: June 10, 2026
An overview of the clinical development of the 20-valent pneumococcal conjugate vaccine in adults.
Journal: Human vaccines & immunotherapeutics
Published: February 09, 2026
Immunogenicity and safety of 20-valent pneumococcal conjugate vaccine in pneumococcal vaccine-naive adults ≥18 years of age in India: A phase 3 single-arm trial.
Journal: Human vaccines & immunotherapeutics
Published: January 08, 2026
A Phase 3, Single-arm Trial to Evaluate the Safety and Immunogenicity of a 20-Valent Pneumococcal Conjugate Vaccine in Healthy Children 15 Months Through <18 Years of Age.
Journal: The Pediatric infectious disease journal
Published: March 19, 2024
A phase 3 randomized trial of the safety and immunogenicity of 20-valent pneumococcal conjugate vaccine in adults ≥ 60 years of age in Japan, South Korea, and Taiwan.
Journal: Vaccine
Published: November 13, 2023
Showing 1-8 of 8
Last Updated: 09/26/2026